Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Ambrisentan for use in the treatment of acute renal failure

Ambrisentan for use in the treatment of acute renal failure

US Patent 10870021 · Granted Dec 22, 2020

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treatment of portal hypertension and cirrhosis2024
Ambrisentan for use in the treatment of acute renal failure2023
Spaced drug delivery system2011
Controlled release drug delivery device1997
Oral therapeutic system having systemic action1995
Inhaler1994
Methanediphosphonic acid formulations with ion exchangers1994
Inhaler1993
Vibratory process and apparatus for agglomerating and metering non-flowable powd1992
Oral forms of administration with delayed release1992
Coated adhesive tablets1992
Therapeutic system for sparingly soluble active ingredients1991